a b s t r a c t T lymphocyte migration is crucial for adaptive immunity. Manipulation of signaling molecules controlling cell migration combined with in vitro cell migration analysis provides a powerful research approach. Microfluidic devices, which can precisely configure chemoattractant gradients and allow quantitative single cell analysis, have been increasingly applied to cell migration and chemotaxis studies. However, there are a very limited number of published studies involving microfluidic migration analysis of genetically manipulated immune cells. In this study, we describe a simple microfluidic method for quantitative analysis of T cells expressing transfected chemokine receptors and other cell migration signaling probes. Using this method, we demonstrated chemotaxis of Jurkat transfectants expressing wild type or C terminus mutated CCR7 within a gradient of chemokine CCL19, and characterized the difference in transfectant migration mediated by wild type and mutant CCR7. The EGFP tagged CCR7 allows identification of CCR7 expressing transfectants in cell migration analysis and microscopy assessment of CCR7 dynamics. Collectively, our study demonstrated the effective use of the microfluidic method for studying CCR7 mediated T cell transfectant migration. We envision this developed method will provide a useful platform to functionally test various signaling mechanisms at the cell migration level.
Introduction
Chemoattractant concentration gradient directed immune cell migration (chemotaxis) critically orchestrates the trafficking and homing of various immune cell types in tissues (Cahalan and Parker, 2008; Jin et al., 2008; Gambardella and Vermeren, 2013; Heuzé et al., 2013) . T lymphocytes are the key players in adaptive immunity (Garside et al., 1998; Miller et al., 2002; Bromley et al., 2008; John et al., 2009 ). These cells have highly regulated tissue specific migratory properties (Campbell and Butcher, 2000; Moser and Loetscher, 2001; Kunkel and Butcher, 2002) . In particular, chemokine receptor CCR7 is required for naïve and central memory T cell migration to lymph nodes (LN), which is important to initiate adaptive immune response and immune surveillance (Forster et al., 1999 (Forster et al., , 2008 Gunn et al., 1999) . Chemokine CCL21, a ligand for CCR7, is highly expressed in LN and is responsible for T cell recruitment to LN (Ngo et al., 1998; Luther et al., 2002) . Chemokine CCL19, another ligand for CCR7, is a potent chemoattractant for CCR7 expressing T cells in vitro. However, CCL19 is only produced in LN at low level and seems not to participate in T cell recruitment to LN (Luther et al., 2002; Link et al., 2007) . CCL19 but not CCL21 triggers robust CCR7 desensitization and internalization (Bardi et al., 2001; Kohout et al., 2004) . Interestingly, deletion of the C terminus of CCR7 does not completely inhibit the CCL19 induced internal ization (Otero et al., 2008) . The mechanisms underlying these unique features of CCR7 and their roles in mediating T cell migration are not clear. Further studies to better understand CCR7 mediated T cell migration will benefit from an advanced experimental platform, which is capable of quantitative single cell migration analysis and imaging studies of cell migration signaling at the molecular level in well defined chemical gradients.
Most in vitro studies of T cell migration employed the conventional transwell assay. Its capacity is limited by poor gradient control and inability to visualize migrating cells (Keenan and Folch, 2008) . Microfluidic devices, which can precisely configure gradient conditions, offer useful tools for cell migration and chemotaxis studies (Li and Lin, 2011; Wu et al., 2013) . Previously, we used a microfluidic gradient generating device to study the migration of activated human peripheral blood T cells (ahPBT) (Lin and Butcher, 2006; Nandagopal et al., 2011) . Microfluidic devices were also used to study the migration of other subsets of human peripheral blood T cells such as memory T cells (Lin et al., 2008) . However, there have been few reports for studying signaling mechanisms in chemotaxing immune cells by combining genetic manipu lations and controlled chemoattractant gradient profiles gen erated by microfluidic devices, especially in lymphocytes (Long et al., 2004; Sai et al., 2006; Cavnar et al., 2011) . Among them, several studies employed microfluidic devices to study chemo tactic signaling for neutrophil chemotaxis using neutrophil like cell lines expressing transfected mutants of specific signaling molecules such as CXCR2 (Sai et al., 2006) and Hax1 . We previously employed a microfluidic gradient generator to quantitatively evaluate the role of tandem PH domain containing protein 2 (TAPP2) for regulating malignant B lymphocyte migration (Li et al., 2013) . However, the effective use of microfluidic device for studying T cell transfectants chemotaxis targeting specific signaling mechanisms has not been demonstrated.
The potential of advanced microfluidic platforms to study chemotaxis mechanisms in immune cells is strengthened by recent development of molecular probes and imaging technol ogies (Wang et al., 2008; Deng et al., 2011) . Immunofluores cence staining against specific cell surface and intracellular markers is a well established technique (Fritschy and Härtig, 2001; Robinson et al., 2010) . For example, this method can be used to visualize surface distribution and endocytosis of chemoattractant receptors as well as cytoskeleton in migrating cells at the time point of interest (Ballestrem et al., 1998; Otero et al., 2006) . In addition, advanced methods were developed to visualize the dynamics of signaling events in migrating cells in real time (Servant et al., 2000; Ridley et al., 2003; Riedl et al., 2008; Arai et al., 2010) . New F actin binding probes have become available for real time visualization of cytoskeleton dynamics in cell migration (Riedl et al., 2008) . State of the art imaging modules such as confocal and total internal reflection fluorescence microscopy (TIRF) have been widely used in cell migration research to enable high resolution molecular imag ing (Blow, 2007) . It will provide a powerful research approach for studying T cell migration and chemotaxis by integrating molecular imaging with microfluidic devices.
The main goal of the present study is to demonstrate the feasibility of combining a microfluidic gradient generator with molecular immunology methods to quantitatively analyzing the migration of genetically modified T cell transfectants. We wanted to determine whether chemotactic signaling constructs can be effectively transfected to T cells and mediate functional migration and chemotaxis of the T cell transfectants in microfluidic devices. Furthermore, we wanted to examine the function of both wild type (wt) CCR7 and C terminus mutated CCR7 in mediating T cell transfectant chemotaxis in the microfluidic system.
Materials and methods

Plasmid construction
Lifeact RFP plasmid was purchased from ibidi GmbH. The CCR7 WT and CCR7 WT EGFP plasmids were described previ ously (Otero et al., 2008) . The CCR7 C terminus truncated sequence was generated by polymerase chain reaction (PCR) using primer design 5′ ATA GAA TTC CGT CAT GGA CCT GGG GAA AC 3′ (EcoRI) (restriction site underlined) and 5′ TGC GGC CGC GCC CAG GTC CTT GAA GAG C 3′ (NotI) (restriction site underlined) based on CCR7 truncation site. This PCR product was digested by EcoRI and NotI and ligated into pcDNA3 CCR7 WT EGFP vector to remove CCR7 WT. After transformation into competent Escherichia coli, clones contain ing the truncated CCR7 insert were sequence verified.
Cell line and transfection
Jurkat T cells (human leukemia T cell) were cultured in RPMI 1640 medium containing 10% fetal calf serum (FCS) and 1% penicillin streptomycin (P/S). Transient transfections were carried out by the Neon Transfection System following the manufacturer's protocol. Cells were passaged one day before transfection. 2.5 × 10 5 cells were resuspended in the R buffer containing 1 μg plasmid in a 10 μL Neon tip for each electro poration. The cells were electroporated at 1325 V pulse voltage, 10 ms pulse width for 3 pulses.
Cell surface receptor expression
CCR7 transfected Jurkat cells were stained with anti CCR7 Alexa647 (BD Biosciences) for 30 min on ice. After washing twice, cells were analyzed by flow cytometry using a flow cytometer (FACS Canto II, BD Biosciences). The flow data were further analyzed using Flowjo (Tree Star, OR).
Transwell assay
Transwell assays (Corning Inc, NY) were performed across bare polycarbonate membranes. Briefly, 5 × 10 5 cells in 100 μL of medium were added to the top well of a 6.5 mm diameter transwell culture insert with a pore size of 5 μm. The insert was then transferred to wells containing 600 μL of medium with or without different concentrations of chemoattractants. Cells were allowed to migrate in the transwell assay for 4 h at 37°C with 5% CO 2 . Transmigrated cells into the lower well were resuspended in medium and collected for counting using a flow cytometer (FACS Canto II, BD Biosciences). The migration rate was measured as the percentage of the total input cells that migrated into the lower well. The flow data were further analyzed using Flowjo. At least triplicate was performed for the medium control group and CCL19 group.
Internalization of CCR7
CCR7 WT EGFP or CCR7 MT EGFP transfected Jurkat cells were stimulated with 100 nM CCL19 or 100 nM CCL21 for defined period of time. Cells were then quickly fixed with 4% paraformaldehyde (PFA) in PBS for 30 min at room temperature. Then cells were washed twice and stained with anti CCR7 Alexa647 antibody (BD Biosciences) for 30 min on ice. After washing twice, cells were analyzed by flow cytometry. The flow data were further analyzed using Flowjo. The mean fluorescence intensity (MFI) was measured and normalized to the control condition without chemokine stimulation to indicate the relative level of surface CCR7 expression.
PDMS microfluidic device preparation and gradient generation
The microfluidic devices used for cell migration experiments in this study were designed in Freehand 9.0 (Macromedia) and the design was printed to a transparency mask by a high resolution printer. The masters were fabricated in The Nano Systems Fabrication Laboratory (NSFL) at the University of Manitoba. The design was patterned on a silicon wafer by contact photolithography with SU 8 photoresist (Micro Chem, MA) through the transparency mask and the SU 8 pattern yields 100 μm thickness The PDMS replicas were then fabricated by molding Polydimethylsiloxane (PDMS)(Sylgard 184 silicon elastomer, Dow Corning, MI) against the master. One millimeter Fig. 1 . Chemotaxis of parental Jurkat cells or Jurkat transfectant expressing Lifeact-RFP to a SDF-1α gradient using the microfluidic platform. A) Cell movement paths were tracked for parental Jurkat cells migrating under a 100 nM SDF-1α gradient with higher SDF-1α concentration at the top (red: toward the gradient; blue: away from the gradient). B) Plot of cell tracks in A) normalized to a common origin (red: toward the gradient; blue: away from the gradient). C) A Lifeact-RFP Jurkat transfectant migrating toward a 100 nM SDF-1α gradient.
diameter holes for fluidic inlets and a 4 mm diameter hole for the fluidic outlet were punched out of PDMS respectively in each device. An additional 1 mm hole was punched for loading cells. Then the PDMS replica was bonded to a glass slide using an air plasma cleaner (PDC 32G, Harrick Plasma, NY). Polyethylene tubing (PE 20, Becton Dickinson, MD) was inserted into the inlet holes to connect the microfluidic device to syringe pumps (KDS 200, KD Scientific, MA) with two 1 mL BD TB syringes containing migration medium or chemokine solutions for fluidic infusion. Chemokine solutions (Recombinant Human CCL19/ MIP 3 beta and Recombinant Human CCL21/6Ckine from R&D Systems; Recombinant Human SDF 1α/CXCL12 from Peprotech) of suitable concentrations were prepared in migration medium (RPMI 1640 with 0.4% BSA). The migra tion medium and chemokine solutions were continuously infused into the device by syringe pumps through tubing and the inlets of the device at the total flow rate of 0.4 μL/min. The defined stable chemokine gradients are generated by controlled mixing of laminar flows of chemokines and medium. The mechanism for generating controlled stable chemical gradient in the "Y" device was characterized both experimentally and theoretically (Lin and Butcher, 2006) . The cells were imaged~3 mm downstream of the "Y" junction.
Microfluidic cell migration experiments and confocal microscopy
The microfluidic cell migration experiment was per formed following the similar method described previously (Nandagopal et al., 2011) . The fluidic channel was coated with fibronectin (BD Biosciences, MA) for 1 h at room temperature and blocked with BSA for another hour before the experiment. For each experiment, cells were loaded into the microfluidic device from the wells and allowed to settle in the fibronectin coated channel for~5 min. The device was maintained at 37°C and 5% CO 2 using a stage incubator (PECON, Germany). Transfectants migration was imaged using a 10× objective with a CSU X1M 5000 spinning disc confocal microscope (Carl Zeiss Canada). Cell migration in the applied gradient fields was recorded by time lapse microscopy at 1 frame/min for 15 100 min using a CCD camera (Q32511, QIMAGING, Canada). A 63× objective was used to image CCR7 expression and internalization. A 488 nm solid state laser was used for imaging EGFP expression of the CCR7 transfectants and a 561 nm solid state laser was used for imaging RFP expression of the LifeAct transfectants. DIC images were taken in parallel. The image acquisition was controlled by ZEN2012 (Zeiss, Germany).
Quantitative data analysis
Movement of individual cells was tracked using NIH ImageJ (v.1.47). The images were calibrated to distance. Only the cells that migrated within the microscope field throughout the time lapse period were selected and tracked using the "Manual Tracking" plug in in NIH ImageJ. The tracking data were exported to Excel. 32 196 cell tracks in each individual experiment were analyzed. EGFP+ cells were identified from the fluorescence images and then the corresponding cells were tracked using the DIC images for better tracking accuracy. At least 2 independent experiments were repeated for each condition with similar results. The figure used data from one representative experiment for each condition.
Following previously established analysis methods, the movement of cells was quantitatively evaluated by (1) the percentage of cells that migrated toward the chemokine gradient; (2) Chemotactic Index (C.I.), which is the ratio of the displacement of cells toward the chemokine gradient (Δy), to the total migration distance (d) using the equation C.I. = Δy/d, presented as the average value ± standard error of the mean (SEM); (3) the average cell migration speed calculated as d/Δt and presented as the average value ± SEM of all cells. ibidi Chemotaxis tool (ibidi GmbH Munich), and MATLAB (The Math Works. Inc, MA) were used for data analysis.
Statistical analysis
Statistical analyses were performed using Graphpad Prism 6 (GraphPad Software. Inc, CA). Student's t test was applied for statistical comparison of the data between different conditions (*p b 0.05; **p b 0.01; ***p b 0.001; ****p b 0.0001). p b 0.05 is considered significantly different.
Results
Migration of parental Jurkat cells and LifeAct RFP transfectants to a SDF 1α gradient
Jurkat cells express CXCR4, a receptor for chemokine SDF 1α/CXCL12. Thus, we first used parental Jurkat cells to demonstrate the effective use of the microfluidic system for analyzing Jurkat cell migration and chemotaxis. Our results show that majority of the cells migrated toward a 100 nM SDF 1α gradient in the microfluidic device [ Fig. 1A B] . We also transiently transfected Jurkat cells with Lifeact RFP (an F actin binding probe) and tested the Lifeact RFP Jurkat transfectants migration in a 100 nM SDF 1α gradient in the microfluidic device. We were able to observe individual Lifeact RFP Jurkat transfectant migrating toward the gradient [Fig. 1C ]. The dynamic F actin organization in chemotaxing cell was visual ized by the Lifeact RFP signal [ Fig. 1C ; Video S1].
Generation and characterizations of CCR7 Jurkat transfectants
Our Jurkat cells express CCR7 at negligible low level ( Fig. 2A) . Therefore, these cells can be used as a parental T cell line for expressing transfected CCR7. We generated Jurkat transfectants expressing transfected EGFP tagged wild type CCR7 (CCR7 WT EGFP). CCR7 WT EGFP showed significant correlation between EGFP and CCR7 [ Fig. 2A ]. The membrane bound CCR7 WT EGFP expression in transfectants was con firmed by confocal microscopy [ Fig. 2B ]. Furthermore, surface CCR7 WT EGFP in the Jurkat transfectants can be functionally internalized upon cellular stimulation with its ligand CCL19 as shown by confocal microscopy and FACS [ Fig. 2C D] . By contrast, CCL21, another ligand for CCR7, induces a much lower level of internalization [ Fig. 2D ], which is consistent with the literatures (Kohout et al., 2004; Otero et al., 2008) . These results established that CCR7 WT EGFP expressed in Jurkat cells is membrane associated and differentially responds to CCL19 and CCL21 ligands.
Migration of CCR7 WT EGFP transfectants to CCL19 gradients
In traditional transwell assays, the migration rate of CCR7 WT EGFP Jurkat transfectants to CCL19 is generally very low although it is significantly higher than the medium control [ Fig. 2E ]. The migration rate of the CCR7 WT EGFP Jurkat transfectants to SDF 1α mediated by endogenously expressed CXCR4 is higher [ Fig. 2E ]. Therefore, we believe the microfluidic based single cell migration analysis method is advantageous for studying lymphocyte transfectant migration. Using the microfluidic platform, we tested the migration of CCR7 WT EGFP Jurkat transfectants in two different CCL19 gradients, i.e. a single 10 nM CCL19 gradient and a single 100 nM CCL19 gradient. Our results show that 92.2% of the cells migrate toward the 100 nM CCL19 gradient whereas only 60% of cells migrated toward the 10 nM CCL19 gradient. This difference is confirmed by the cell migration trajectories and Chemotactic Index [Fig. 3A B; Video S2]. The cell migration speed is comparable in the 10 nM and 100 nM CCL19 gradients [ Fig. 3B ]. These results demonstrated the expected dose dependent chemotaxis of CCR7 Jurkat transfectants to CCL19 gradients.
Migration of mutated CCR7 Jurkat transfectants to CCL19 gradients
We modified the previously characterized CCR7 MT2 mutant (the last 34 amino acids in the C terminus were deleted) (Otero et al., 2008) by adding an in frame EGFP tag (for simplicity, we defined this construct as CCR7 MT EGFP in this study) [Fig. 4A ]. CCL19 induced internalization of CCR7 MT EGFP was found to be reduced [ Fig. 4B ] consistent with the previous study using CCR7 MT2 pre B cell transfectants (Otero et al., 2008) . When the 10 nM CCL19 was applied in the microfluidic device, chemotaxis of CCR7 MT EGFP Jurkat transfectants was enhanced compared to that of the CCR7 WT EGFP transfectants [ Fig. 4C D] . The cell migration speed is comparable between CCR7 WT EGFP and CCR7 MT EGFP Jurkat transfectants. These results demonstrate that the microfluidic device system is able to detect modified chemo tactic behavior determined by the chemokine gradient condi tion and CCR7 cytoplasmic tail.
Discussion
Genetic manipulations often affect cells' migration func tions. Electroporation based transfection methods disrupt cell membrane integrity (Chen et al., 2006; Kim and Eberwine, 2010) , which can significantly influence the transfectants' adhesion and migration abilities. Compromise between trans fection efficiency and cell recovery after electroporation further complicates the use of the transfectants for migration studies. On the other hand, generation of stable transfectant lines is more time consuming and the transfectants can undergo genotypic and phenotypic changes over the clonal selection process. The complex cellular machinery operated by immune cells makes it less amenable to signaling interventions compar ing to other well established eukaryotic cell models such as Dictyostelium discoideum and yeast (Arkowitz, 1999; Iglesias, 2009; King and Insall, 2009; Lee and Jeon, 2012; Artemenko et al., 2014; Flor Parra et al., 2014) . Our study addressed these challenges by optimizing the transfectant generation and microfluidic system. We successfully demonstrated the feasibility of studying the migration of transient CCR7 trans fectants in a relevant T cell line using a simple microfluidic gradient generator. Optimization of transfection efficiency and positive transfectants identification by EGFP tag makes this approach suitable for efficient cell migration analysis. We believe this developed method provides useful strategies for designing successful microfluidic cell migration studies with genetically manipulated T cell transfectants. It is worth pointing out that most experiments of this study were performed in an immu nology lab with an in house microfluidic device fabrication facility that demonstrates the feasibility of this approach.
In this study, we followed a previously reported strategy (Otero et al., 2008) to examine the C terminus function of CCR7 for mediating T cell migration and chemotaxis. The specific CCR7 mutant with partial C terminus truncation has been shown to be capable of undergoing CCL19 induced internali zation in pre B 300 19 transfectants (Otero et al., 2008) . On the other hand, although not rigorously characterized, the mutant CCR7 mediates reduced CCR7 internalization in response to CCL19 stimulation comparing to wt CCR7 (Otero et al., 2008) . In addition, the mutant CCR7 mediates similar chemotaxis of pre B 300 19 transfectants comparing to wt CCR7 using transwell assays (Otero et al., 2008) . In the present study, we also observed a general trend of reduction of CCL19 induced internalization of the mutant CCR7 in Jurkat transfectants comparing to wt CCR7. The exact time dependent dynamics of CCL19 induced CCR7 internalization can vary among different sets of experiments. Furthermore, we showed functional chemotaxis of mutant CCR7 transfectants in Jurkat cells to CCL19 gradients. In majority of the experiments to examine the migration of mutant CCR7 transfectants to a low dose CCL19 gradient, we observed an enhancement of chemotaxis, which is expected to result from the reduced CCR7 internalization. Further studies are required to draw concrete conclusions on the role of C terminus functions of CCR7 in mediating CCR7 signaling and T cell migration.
Supplementary data to this article can be found online at http://dx.doi.org/10.1016/j.jim.2015.02.008.
